Royal Biologics Launches Fibri-Cell Cortical Fibers

Royal Biologics FIBRI-CELL

Royal Biologics introduced FIBRI-CELL™ to enhance traditional bone graft substitutes for orthopedic fusion procedures. FIBRI-CELL complements the company's FIBRINET technology, acquired from Vertical Spine earlier this year.

FIBRI-CELL utilizes Royal's Osteo-Spin™ technology to deliver activated platelets, bone marrow aspirate and...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0